ABBV-744 IN COMBINATION WITH IMMUNOTHERAPY - AN OVERVIEW

As well as People clinical trials described previously mentioned, there have also been pre-clinical studies that showed excellent efficiency with regard to the two safety and effectiveness in opposition to AML.- "Our study revealed the essential function of your KLF16/MYC regulatory axis in modulating tumor advancement and chemotherapy sensitivity